series-a
Stage
About
Samsara Therapeutics develops therapeutics targeting neurodegenerative diseases by activating autophagy pathways, focusing on conditions such as ALS, Parkinson's Disease, and Charcot-Marie-Tooth disease.
Explore Samsara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.